News Headlines Article

FDA user-fee legislation moves toward final vote
Modern Healthcare

Legislation to reauthorize the Food and Drug Administration’s drug and device user-fee system for another five years cleared a final procedural hurdle Monday night and faces its final congressional vote Tuesday.

The Senate voted 89-3 to advance the bill, which is a negotiated compromise between similar measures that separately passed the House and Senate last month. The House of Representatives passed the compromise measure—one of the few major pieces of legislation to advance in both chambers this year—on June 20.